Nothing Special   »   [go: up one dir, main page]

MX2008008261A - Intercambio nucleotidico dirigido mejorado con oligonucleotidos modificados por lna. - Google Patents

Intercambio nucleotidico dirigido mejorado con oligonucleotidos modificados por lna.

Info

Publication number
MX2008008261A
MX2008008261A MX2008008261A MX2008008261A MX2008008261A MX 2008008261 A MX2008008261 A MX 2008008261A MX 2008008261 A MX2008008261 A MX 2008008261A MX 2008008261 A MX2008008261 A MX 2008008261A MX 2008008261 A MX2008008261 A MX 2008008261A
Authority
MX
Mexico
Prior art keywords
nucleotide
modified oligonucleotides
nucleotide exchange
lna modified
targeted nucleotide
Prior art date
Application number
MX2008008261A
Other languages
English (en)
Inventor
Paul Bundock
Both Michiel Theodoor Jan De
Rene Cornelis Josephus Hogers
Ludvik Kevin Wachowski
Original Assignee
Keygene Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36691461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2008008261(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Keygene Nv filed Critical Keygene Nv
Publication of MX2008008261A publication Critical patent/MX2008008261A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • C12N15/8278—Sulfonylurea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6832—Enhancement of hybridisation reaction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe un método y se proporcionan oligonucleótidos para intercambio nucleotídico dirigido de una secuencia de ADN duplex, en donde el oligonucleótido donador contiene por lo menos un nucleátido modificado el cual es un LNA que tiene una afinidad de unión mayor en comparación con A, C, T o G como se encuentran de manera natural y/o que se unen con mayor fuerza a un nucleótido en una posición opuesta en la primera secuencia de ADN en comparación con un nucleótido como se encuentra de manera natural complementario al nucleótido en la posición opuesta en la primera secuencia de ADN.
MX2008008261A 2005-12-22 2006-12-21 Intercambio nucleotidico dirigido mejorado con oligonucleotidos modificados por lna. MX2008008261A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2005/000884 WO2007073149A1 (en) 2005-12-22 2005-12-22 Alternative nucleotides for improved targeted nucleotide exchange
PCT/NL2006/000244 WO2007073154A1 (en) 2005-12-22 2006-05-09 Alternative nucleotides for improved targeted nucleotide exchange
PCT/NL2006/000653 WO2007073170A1 (en) 2005-12-22 2006-12-21 Improved targeted nucleotide exchange with lna modified oligonucleotides

Publications (1)

Publication Number Publication Date
MX2008008261A true MX2008008261A (es) 2008-09-24

Family

ID=36691461

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008008258A MX2008008258A (es) 2005-12-22 2006-12-20 Intercambio de nucleotidos dirigido mejorado con oligonucleotidos modificados con propinilo.
MX2008008261A MX2008008261A (es) 2005-12-22 2006-12-21 Intercambio nucleotidico dirigido mejorado con oligonucleotidos modificados por lna.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2008008258A MX2008008258A (es) 2005-12-22 2006-12-20 Intercambio de nucleotidos dirigido mejorado con oligonucleotidos modificados con propinilo.

Country Status (15)

Country Link
US (3) US20090307805A1 (es)
EP (4) EP2333115A1 (es)
JP (3) JP5295780B2 (es)
KR (2) KR20080092924A (es)
CN (3) CN101346474B (es)
AU (2) AU2006328050B2 (es)
BR (2) BRPI0621134A2 (es)
CA (2) CA2633741A1 (es)
ES (2) ES2393277T3 (es)
IL (2) IL192165A0 (es)
MX (2) MX2008008258A (es)
NZ (2) NZ569503A (es)
RU (2) RU2008130093A (es)
WO (4) WO2007073149A1 (es)
ZA (2) ZA200805091B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073149A1 (en) * 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
RU2010101882A (ru) * 2007-06-22 2011-07-27 Киджин Н.В. (Nl) Направленная нуклеотидная замена при применении улучшенных модифицированных олигонуклеотидов
JP5731201B2 (ja) * 2007-12-21 2015-06-10 キージーン ナムローゼ フェンノートシャップ 植物細胞プロトプラストにおける二本鎖アクセプタｄｎａ配列の標的化改変の方法
CN103146757B (zh) * 2007-12-21 2016-05-04 凯津公司 通过聚乙二醇的介导将致诱变核碱基引入植物原生质体的改进的诱变方法
US20110312094A1 (en) * 2008-12-22 2011-12-22 Keygene N.V. Use of double stranded rna to increase the efficiency of targeted gene alteration in plant protoplasts
CN104651394A (zh) 2009-12-21 2015-05-27 凯津公司 用于转染原生质体的改进技术
CA2819423C (en) 2010-12-02 2020-12-22 Keygene N.V. Targeted alteration of dna
WO2012074386A1 (en) 2010-12-02 2012-06-07 Keygene N.V. Targeted alteration of dna with oligonucleotides
WO2012148275A1 (en) 2011-04-29 2012-11-01 Keygene N.V. Glyphosate resistance enhancement
RU2584573C2 (ru) 2011-06-15 2016-05-20 Грайфолз Терепьютикс Инк. Способы, композиции и наборы для определения вируса иммунодефицита человека (вич)
EP2554045A1 (en) 2011-08-04 2013-02-06 Rijk Zwaan Zaadteelt en Zaadhandel B.V. Method for systemically influencing processes in the male meiocyte
ES2535654T3 (es) * 2011-10-13 2015-05-13 Association Institut De Myologie ADN triciclo-fosforotioato
CN102827251B (zh) * 2012-09-12 2014-06-18 中国人民解放军第四军医大学 一种透膜肽介导的反义抗菌剂及其制备方法和应用
PL2900817T3 (pl) 2012-09-28 2022-03-07 Nunhems B.V. Rośliny solanum lycopersicum zawierające nietransgeniczne zmiany w genie acs4
US9832943B2 (en) 2012-11-21 2017-12-05 Nunhems B.V. Solanum lycopersicum plants having non-transgenic alterations in the Acs2 gene
EA032350B1 (ru) 2013-01-31 2019-05-31 Нунхемс Б.В. Растения solanum lycopersicum, имеющие розовые плоды
ES2921207T3 (es) 2013-03-15 2022-08-19 Cibus Us Llc Procedimientos y composiciones para aumentar la eficiencia de la modificación genética direccionada utilizando la reparación genética mediada por oligonucleótidos
US9957515B2 (en) 2013-03-15 2018-05-01 Cibus Us Llc Methods and compositions for targeted gene modification
JP2013247961A (ja) * 2013-08-21 2013-12-12 Keygene Nv 植物細胞プロトプラストにおける二本鎖アクセプタｄｎａ配列の標的化改変の方法
KR102569558B1 (ko) 2014-03-14 2023-08-22 시버스 유에스 엘엘씨 올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형의 효율을 증가시키기 위한 방법 및 조성물
CN107532162A (zh) * 2014-12-12 2018-01-02 托德·M·伍尔夫 用于利用寡核苷酸编辑细胞中核酸的组合物和方法
WO2016105185A1 (en) 2014-12-22 2016-06-30 Keygene N.V. Plant callus populations
US11136618B2 (en) * 2015-05-19 2021-10-05 The University Of Chicago Methods and compositions for determining pH
EP3402745B1 (en) * 2015-12-23 2023-07-26 The Regents of the University of California Nano-sensors for nucleic acid detection and discrimination
CA3014036A1 (en) * 2016-02-09 2017-08-17 Cibus Us Llc Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
EP3257944A1 (en) 2016-06-14 2017-12-20 Nunhems B.V. Tomato plants having alterations in the dmr6 gene
WO2018115389A1 (en) 2016-12-22 2018-06-28 Keygene N.V. Methods of targeted genetic alteration in plant cells
WO2019140009A1 (en) 2018-01-09 2019-07-18 Cibus Us Llc Shatterproof genes and mutations
NL2020823B1 (en) 2018-04-25 2019-11-05 Univ Delft Tech NAD+ dependent 7ß-hydroxysteroid dehydrogenase
EP3363751B1 (de) 2018-06-05 2020-04-22 B&R Industrial Automation GmbH Verfahren zur übergabe einer transporteinheit eines langstatorlinearmotors an einer übergabeposition
JP7396770B2 (ja) 2018-07-12 2023-12-12 キージーン ナムローゼ フェンノートシャップ 植物細胞におけるゲノム編集のためのｖ型ｃｒｉｓｐｒ／ヌクレアーゼシステム
EP3874048A1 (en) 2018-11-01 2021-09-08 Keygene N.V. Dual guide rna for crispr/cas genome editing in plants cells
CN114262735A (zh) * 2021-12-15 2022-04-01 成都齐碳科技有限公司 用于表征多核苷酸的衔接体及其用途
WO2023168273A2 (en) * 2022-03-01 2023-09-07 Colorado State University Research Foundation Targeted control of weeds and invasive plants by delivery of fana antisense oligonucleotides

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US645249A (en) * 1899-06-10 1900-03-13 Us Fire And Police Telegraph Company Bell-striker.
US5849482A (en) * 1988-09-28 1998-12-15 Epoch Pharmaceuticals, Inc. Crosslinking oligonucleotides
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
MX9207334A (es) 1991-12-18 1993-08-01 Glaxo Inc Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
US5731181A (en) * 1996-06-17 1998-03-24 Thomas Jefferson University Chimeric mutational vectors having non-natural nucleotides
US6043060A (en) 1996-11-18 2000-03-28 Imanishi; Takeshi Nucleotide analogues
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
AU9381598A (en) * 1997-09-10 1999-03-29 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method of amplifying dna and rna mismatch cleavage products
KR100414936B1 (ko) 1997-09-12 2004-01-13 엑시콘 에이/에스 이환 및 삼환 뉴클레오시드, 뉴클레오타이드 및올리고뉴클레오타이드 동족체
US6010907A (en) 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
US6365577B1 (en) * 1998-10-26 2002-04-02 Avi Biopharma, Inc. p53 antisense agent and method
AU777049B2 (en) 1999-03-18 2004-09-30 Qiagen Gmbh Xylo-LNA analogues
KR100782896B1 (ko) 1999-05-04 2007-12-06 엑시콘 에이/에스 Ｌ-리보-ｌｎａ 유사체
EP1244667B1 (en) * 1999-12-30 2006-04-05 K.U. Leuven Research & Development Cyclohexene nucleic acids
US6936467B2 (en) 2000-03-27 2005-08-30 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
WO2001073002A2 (en) * 2000-03-27 2001-10-04 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
EP1152058A1 (en) * 2000-05-03 2001-11-07 Institut Curie Methods and compositions for effecting homologous recombination
WO2001087914A2 (en) 2000-05-17 2001-11-22 University Of Delaware Plant gene targeting using oligonucleotides
AU2001280632A1 (en) * 2000-07-19 2002-01-30 Bristol-Myers Squibb Pharma Company CRF2 ligands in combination therapy
WO2002010364A2 (en) 2000-07-27 2002-02-07 University Of Delaware Methods for enhancing targeted gene alteration using oligonucleotides
WO2002026967A2 (en) * 2000-09-25 2002-04-04 Thomas Jefferson University Targeted gene correction by single-stranded oligodeoxynucleotides
US20050148530A1 (en) * 2002-02-20 2005-07-07 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
EP1446503A2 (en) 2001-09-27 2004-08-18 University Of Delaware Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration
US7737264B2 (en) * 2002-04-05 2010-06-15 Enzon Pharmaceuticals, Inc. Oligomeric compounds for the modulation HIF-1α expression
EP1543155A4 (en) * 2002-07-17 2006-08-16 Us Genomics Inc METHODS AND COMPOSITIONS FOR ANALYZING POLYMERS USING CHIMERIC MARKERS
PL1633767T3 (pl) * 2003-06-02 2019-07-31 University Of Massachusetts Sposoby i kompozycje do kontrolowania wydajności wyciszania rna
CA2546067A1 (en) * 2003-11-14 2005-06-02 Yale University Fcyriia-specific nucleic acid interference
WO2007073149A1 (en) * 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange

Also Published As

Publication number Publication date
KR20080092924A (ko) 2008-10-16
CA2633640A1 (en) 2007-06-28
CN101346466B (zh) 2013-06-12
EP1963505B1 (en) 2012-08-22
RU2008130093A (ru) 2010-01-27
CA2633741A1 (en) 2007-06-28
US20100186124A1 (en) 2010-07-22
EP1963505A1 (en) 2008-09-03
AU2006328050A1 (en) 2007-06-28
RU2463350C2 (ru) 2012-10-10
JP5295780B2 (ja) 2013-09-18
JP2009520499A (ja) 2009-05-28
CN101346466A (zh) 2009-01-14
EP2333115A1 (en) 2011-06-15
ES2407679T3 (es) 2013-06-13
US20090307805A1 (en) 2009-12-10
ES2393277T3 (es) 2012-12-20
KR20080083179A (ko) 2008-09-16
NZ569503A (en) 2011-12-22
RU2008130089A (ru) 2010-01-27
ZA200805091B (en) 2009-06-24
WO2007073149A1 (en) 2007-06-28
BRPI0621134A2 (pt) 2011-11-29
CN101346465B (zh) 2013-06-12
IL192164A0 (en) 2008-12-29
CN101346465A (zh) 2009-01-14
MX2008008258A (es) 2008-09-24
AU2006328054A1 (en) 2007-06-28
WO2007073166A1 (en) 2007-06-28
EP2002001A1 (en) 2008-12-17
EP2002001B1 (en) 2013-03-13
BRPI0621133A2 (pt) 2011-11-29
EP1974053A1 (en) 2008-10-01
JP5340742B2 (ja) 2013-11-13
JP5405121B2 (ja) 2014-02-05
ZA200805141B (en) 2009-09-30
CN101346474B (zh) 2013-06-26
AU2006328050B2 (en) 2012-12-06
AU2006328054B2 (en) 2012-12-13
NZ569502A (en) 2011-12-22
US20100055780A1 (en) 2010-03-04
CN101346474A (zh) 2009-01-14
JP2009520498A (ja) 2009-05-28
WO2007073154A1 (en) 2007-06-28
IL192165A0 (en) 2008-12-29
WO2007073170A1 (en) 2007-06-28
JP2009520495A (ja) 2009-05-28

Similar Documents

Publication Publication Date Title
MX2008008261A (es) Intercambio nucleotidico dirigido mejorado con oligonucleotidos modificados por lna.
WO2006125977A3 (en) Hybrid interfering rna
MX2010012849A (es) Reactivo de lisis, enlace y/o lavado para aislar y/o purificar acidos nucleicos.
WO2007085485A3 (en) Lna modified phosphorothiolated oligonucleotides
WO2005120230A3 (en) POSITIONALLY MODIFIED siRNA CONSTRUCTS
WO2009135093A3 (en) Rnase-h-based assays utilizing modified rna monomers
WO2005079397A3 (en) Anti-microrna oligonucleotide molecules
ZA200903022B (en) Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
IL202530A0 (en) Targeted nucleotide exchange with improved modified oligonucleotides
BRPI0813342A2 (pt) " composição de dna polimerase termoestável, e, métodos para estabilizar e ou realçar a atividade de dna polimerase e para realizar pcr ".
EP1845160A4 (en) NUCLEOTIDE-amplification
WO2010033247A3 (en) Reduced size self-delivering rnai compounds
WO2006126040A8 (en) Bacterial and bacterial associated mirnas and uses thereof
WO2007139723A8 (en) Chemicallymodified oligonucleotide primers for nucleic acid amplification
WO2008087641A3 (en) H19 silencing nucleic acid agents for treating rheumatoid arthritis
WO2007118138A3 (en) Validation of comparative genomic hybridization
WO2009014612A3 (en) Modified nucleotides, methods for making and using same
WO2009002937A3 (en) Methods for isolating long fragment rna from fixed samples
EP2157182A3 (en) Modified short interfering RNA
ZA200801099B (en) Chemically modified short interfering nucleic acid molecules that mediate rna interference
WO2007048244A3 (en) Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides
WO2008001219A3 (en) Cancer therapy using bcl-xl-specific sina
WO2007016455A3 (en) Compositions and methods using aminoglycosides to bind dna and rna
WO2005073380A3 (en) Regulated polymerase iii expression systems and related methods
WO2006096441A3 (en) Reagents, methods and systems to suppress phospholamban expression

Legal Events

Date Code Title Description
FA Abandonment or withdrawal